Su, Jinmei
Li, Mengtao
He, Lan
Zhao, Dongbao
Wan, Weiguo
Liu, Yi
Xu, Jianhua
Xu, Jian
Liu, Huaxiang
Jiang, Lindi
Wu, Huaxiang
Zuo, Xiaoxia
Huang, Cibo
Liu, Xiumei
Li, Fen
Zhang, Zhiyi
Liu, Xiangyuan
Dong, Lingli
Li, Tianwang
Chen, Haiying
Li, Jingyang
He, Dongyi
Lu, Xin
Huang, Anbin
Tao, Yi
Wang, Yanyan
Zhang, Zhuoli
Wei, Wei
Li, Xiaofeng
Zeng, Xiaofeng http://orcid.org/0000-0002-3883-2318
Funding for this research was provided by:
Chinese National Key Technology R&D Program, Ministry of Science and Technology (2017YFC0907601)
Medicine and Health Technology Innovation Project, Chinese Academy of Medical Sciences (2019-I2M-2-008)
zhejiang hisun pharmaceutical co., ltd
Article History
Received: 10 February 2021
Revised: 16 September 2021
Accepted: 24 September 2021
First Online: 28 October 2021
Declarations
:
: An ethics committee at every participating center granted approval of the study protocols and reviewed all amendments.
: All patients provided signed informed consent before they were enrolled in the trial.
: Not applicable.
: None.